Notably, dominant subtypes include LGMD D2, caused by TNPO3 (trasportin 3) mutations affecting TNPO3, and LGMD D4, arising from pathogenic variants in CAPN3 (calpain 3) encoding CAPN3. This evidence concerns the gene TNPO3 and limb-girdle muscular dystrophy.